• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卡塔尔的抗菌药物耐药性:新冠疫情之前及期间的流行情况和趋势

Antimicrobial Resistance in Qatar: Prevalence and Trends before and Amidst the COVID-19 Pandemic.

作者信息

Al Mana Hassan, Abdel Hadi Hamad, Wilson Godwin, Almaslamani Muna A, Abu Jarir Sulieman H, Ibrahim Emad, Eltai Nahla O

机构信息

Biomedical Research Center, Qatar University, Doha P.O. Box 2713, Qatar.

Communicable Diseases Centre, Hamad Medical Corporation, Doha P.O. Box 3050, Qatar.

出版信息

Antibiotics (Basel). 2024 Feb 21;13(3):203. doi: 10.3390/antibiotics13030203.

DOI:10.3390/antibiotics13030203
PMID:38534638
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10967570/
Abstract

Antimicrobial resistance (AMR) is a global healthcare challenge with substantial morbidity, mortality, and management costs. During the COVID-19 pandemic, there was a documented increase in antimicrobial consumption, particularly for severe and critical cases, as well as noticeable travel and social restriction measures that might influenced the spectrum of AMR. To evaluate the problem, retrospective data were collected on bacterial infections and antimicrobial susceptibility patterns in Qatar before and after the pandemic from 1 January 2019 to 31 December 2021, covering 53,183 pathogens isolated from reported infection episodes. The findings revealed a significant resistance pattern for extended-spectrum beta-lactamase-producing (ESBL-EBC), carbapenem-resistant (CR-EBC), and carbapenem-resistant (CRPA), ciprofloxacin-resistant and methicillin-resistant (MRSA). For correlation with social restrictions, ESBL-EBC and MRSA were positively correlated with changing patterns of international travel (ρ = 0.71 and 0.67, respectively; < 0.05), while CRPA was moderately correlated with the number of COVID-19 hospitalized patients (ρ = 0.49; < 0.05). CREBC and CRPA respiratory infections were associated with hospitalized patients (OR: 3.08 and 2.00, respectively; < 0.05). The findings emphasize the challenges experienced during the COVID-19 pandemic and links to international travel, which probably will influence the local epidemiology of AMR that needs further surveillance and control strategies.

摘要

抗菌药物耐药性(AMR)是一项全球性的医疗保健挑战,会带来大量的发病、死亡和管理成本。在新冠疫情期间,有记录显示抗菌药物的使用有所增加,尤其是在重症和危重症病例中,同时还有明显的旅行和社会限制措施,这些措施可能影响了AMR的范围。为评估该问题,收集了卡塔尔在疫情前后(2019年1月1日至2021年12月31日)细菌感染及抗菌药物敏感性模式的回顾性数据,涵盖了从报告的感染事件中分离出的53183种病原体。研究结果显示,产超广谱β-内酰胺酶(ESBL-EBC)、耐碳青霉烯类(CR-EBC)、耐碳青霉烯类(CRPA)、耐环丙沙星和耐甲氧西林(MRSA)存在显著的耐药模式。为了与社会限制进行相关性分析,ESBL-EBC和MRSA与国际旅行模式的变化呈正相关(分别为ρ = 0.71和0.67;P < 0.05),而CRPA与新冠住院患者数量呈中度相关(ρ = 0.49;P < 0.05)。CREBC和CRPA呼吸道感染与住院患者有关(OR分别为3.08和2.00;P < 0.05)。研究结果强调了新冠疫情期间所面临的挑战以及与国际旅行的联系,这可能会影响AMR的当地流行病学,需要进一步的监测和控制策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5365/10967570/4ec8b4f1f33f/antibiotics-13-00203-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5365/10967570/2842c10a7aa1/antibiotics-13-00203-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5365/10967570/2ef6fe49f4a9/antibiotics-13-00203-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5365/10967570/4ec8b4f1f33f/antibiotics-13-00203-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5365/10967570/2842c10a7aa1/antibiotics-13-00203-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5365/10967570/2ef6fe49f4a9/antibiotics-13-00203-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5365/10967570/4ec8b4f1f33f/antibiotics-13-00203-g003.jpg

相似文献

1
Antimicrobial Resistance in Qatar: Prevalence and Trends before and Amidst the COVID-19 Pandemic.卡塔尔的抗菌药物耐药性:新冠疫情之前及期间的流行情况和趋势
Antibiotics (Basel). 2024 Feb 21;13(3):203. doi: 10.3390/antibiotics13030203.
2
Bacterial Epidemiology and Antimicrobial Resistance Profiles in Children Reported by the ISPED Program in China, 2016 to 2020.中国 ISPED 项目报告的 2016 至 2020 年儿童细菌流行病学和抗菌药物耐药性特征。
Microbiol Spectr. 2021 Dec 22;9(3):e0028321. doi: 10.1128/Spectrum.00283-21. Epub 2021 Nov 3.
3
Impact of COVID-19 pandemic on multidrug resistant gram positive and gram negative pathogens: A systematic review.新冠疫情对耐多药革兰阳性和革兰阴性病原体的影响:系统综述。
J Infect Public Health. 2023 Mar;16(3):320-331. doi: 10.1016/j.jiph.2022.12.022. Epub 2022 Dec 31.
4
Impact of COVID-19 on Antimicrobial Consumption and Spread of Multidrug-Resistance in Bacterial Infections.2019冠状病毒病对细菌感染中抗菌药物使用及多重耐药性传播的影响
Antibiotics (Basel). 2022 Apr 18;11(4):535. doi: 10.3390/antibiotics11040535.
5
[The Change in Antimicrobial Resistance During the COVID-19 Pandemic in Türkiye].[土耳其2019年冠状病毒病大流行期间抗菌药物耐药性的变化]
Mikrobiyol Bul. 2023 Oct;57(4):507-534. doi: 10.5578/mb.20239943.
6
Regional Variation of Extended-Spectrum Beta-Lactamase (ESBL)-Producing Enterobacterales, Fluoroquinolone-Resistant and Methicillin-Resistant Among Febrile Patients in Sub-Saharan Africa.撒哈拉以南非洲发热患者中产超广谱β-内酰胺酶(ESBL)肠杆菌科细菌、耐氟喹诺酮和耐甲氧西林的区域差异
Front Microbiol. 2020 Sep 25;11:567235. doi: 10.3389/fmicb.2020.567235. eCollection 2020.
7
Impact of coronavirus disease 2019 (COVID-19) on antimicrobial resistance among major pathogens causing healthcare-associated infection.2019 年冠状病毒病(COVID-19)对主要医院获得性感染病原体的抗生素耐药性的影响。
J Formos Med Assoc. 2024 Jan;123(1):123-132. doi: 10.1016/j.jfma.2023.06.026. Epub 2023 Jul 12.
8
A parallel and silent emerging pandemic: Antimicrobial resistance (AMR) amid COVID-19 pandemic.平行且无声的新兴大流行:COVID-19 大流行期间的抗微生物药物耐药性(AMR)。
J Infect Public Health. 2023 Apr;16(4):611-617. doi: 10.1016/j.jiph.2023.02.021. Epub 2023 Feb 21.
9
Assessment of antibiotic resistance patterns in Central Taiwan during the COVID-19 pandemic: A retrospective study.评估 COVID-19 大流行期间台湾中部地区的抗生素耐药模式:一项回顾性研究。
J Infect Public Health. 2024 Feb;17(2):229-235. doi: 10.1016/j.jiph.2023.11.026. Epub 2023 Nov 30.
10
Systematic review and meta-analysis on antimicrobial resistance and drug resistance in Saudi Arabia.沙特阿拉伯抗菌药物耐药性和抗药性的系统评价与荟萃分析。
J Glob Antimicrob Resist. 2024 Dec;39:128-136. doi: 10.1016/j.jgar.2024.07.013. Epub 2024 Aug 27.

引用本文的文献

1
A Review on the Prevalence and Treatment of Antibiotic Resistance Genes in Hospital Wastewater.医院废水中抗生素抗性基因的流行情况与处理综述
Toxics. 2025 Mar 31;13(4):263. doi: 10.3390/toxics13040263.
2
Methicillin-Resistant : The Shifting Landscape in the United Arab Emirates.耐甲氧西林:阿拉伯联合酋长国不断变化的形势
Antibiotics (Basel). 2025 Jan 2;14(1):24. doi: 10.3390/antibiotics14010024.

本文引用的文献

1
The epidemiology and microbiological characteristics of infections caused by Gram-negative bacteria in Qatar: national surveillance from the Study for Monitoring of Antimicrobial Resistance Trends (SMART): 2017 to 2019.卡塔尔革兰氏阴性菌感染的流行病学和微生物学特征:抗菌药物耐药性趋势监测研究(SMART)的全国性监测:2017年至2019年
JAC Antimicrob Resist. 2023 Aug 3;5(4):dlad086. doi: 10.1093/jacamr/dlad086. eCollection 2023 Aug.
2
MRSA compendium of epidemiology, transmission, pathophysiology, treatment, and prevention within one health framework.“同一个健康”框架下耐甲氧西林金黄色葡萄球菌的流行病学、传播、病理生理学、治疗及预防概要
Front Microbiol. 2023 Jan 10;13:1067284. doi: 10.3389/fmicb.2022.1067284. eCollection 2022.
3
Impact of the COVID-19 pandemic on human salmonellosis in the Netherlands.
新冠疫情对荷兰人类沙门氏菌病的影响。
Epidemiol Infect. 2021 Dec 2;149:e254. doi: 10.1017/S0950268821002557.
4
Impact of the COVID-19 Pandemic on the Prevalence of HAIs and the Use of Antibiotics in an Italian University Hospital.新冠疫情对意大利一家大学医院医院获得性感染的发生率及抗生素使用情况的影响
Healthcare (Basel). 2022 Aug 23;10(9):1597. doi: 10.3390/healthcare10091597.
5
Bacterial Co-Infection in Patients with COVID-19 Hospitalized (ICU and Not ICU): Review and Meta-Analysis.COVID-19住院患者(重症监护病房和非重症监护病房)的细菌合并感染:综述与荟萃分析
Antibiotics (Basel). 2022 Jul 4;11(7):894. doi: 10.3390/antibiotics11070894.
6
International Travel as a Risk Factor for Carriage of Extended-Spectrum β-Lactamase-Producing in a Large Sample of European Individuals-The AWARE Study.国际旅行是欧洲人群携带产超广谱β-内酰胺酶的风险因素:AWARE 研究。
Int J Environ Res Public Health. 2022 Apr 14;19(8):4758. doi: 10.3390/ijerph19084758.
7
Antimicrobial resistance (AMR) in COVID-19 patients: a systematic review and meta-analysis (November 2019-June 2021).新冠病毒患者的抗菌药物耐药性:系统评价和荟萃分析(2019 年 11 月至 2021 年 6 月)。
Antimicrob Resist Infect Control. 2022 Mar 7;11(1):45. doi: 10.1186/s13756-022-01085-z.
8
Prevalence of Antibiotic Resistance Over Time in a Third-Level University Hospital.抗生素耐药性随时间在三级大学医院的流行情况。
Microb Drug Resist. 2022 Apr;28(4):425-435. doi: 10.1089/mdr.2021.0109. Epub 2021 Dec 15.
9
Impact of the COVID-19 pandemic on the incidence of multidrug-resistant bacterial infections in an acute care hospital in Brazil.COVID-19 大流行对巴西一家急症医院多重耐药菌感染发病率的影响。
Am J Infect Control. 2022 Jan;50(1):32-38. doi: 10.1016/j.ajic.2021.09.018. Epub 2021 Sep 23.
10
Overview of Changes to the Clinical and Laboratory Standards Institute M100, 31st Edition.临床和实验室标准协会 M100,31 版更改概述。
J Clin Microbiol. 2021 Nov 18;59(12):e0021321. doi: 10.1128/JCM.00213-21. Epub 2021 Sep 22.